Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TTR | P02766 | 2/20 | 0.56 |
| ▸ | FABP4 | P15090 | 1/20 | 0.56 |
| ▸ | CCNA2 | P20248 | 1/20 | 0.56 |
| ▸ | CDK2 | P24941 | 1/20 | 0.56 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.56 |
| ▸ | NR4A1 | P22736 | 1/20 | 0.55 |
| ▸ | CA12 | O43570 | 3/20 | 0.49 |
| ▸ | CA9 | Q16790 | 3/20 | 0.49 |
| ▸ | CA3 | P07451 | 1/20 | 0.49 |
| ▸ | CA4 | P22748 | 1/20 | 0.49 |
| ▸ | CA6 | P23280 | 1/20 | 0.49 |
| ▸ | CA5A | P35218 | 1/20 | 0.49 |
| ▸ | CA7 | P43166 | 1/20 | 0.49 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.49 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.47 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.47 |
| ▸ | TSHR | P16473 | 1/20 | 0.47 |
| ▸ | RECQL | P46063 | 1/20 | 0.47 |
| ▸ | HTR6 | P50406 | 5/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30950399 | 1.00 | TTR (0.56) | TTRFABP4CCNA2CDK2MAPK14 | |
| SCHEMBL21857967 | 0.91 | TTR (0.54) | TTRFABP4CCNA2CDK2MAPK14 | |
| SCHEMBL30461559 | 0.84 | CA12 (0.47) | TTRFABP4CCNA2CDK2MAPK14 | |
| SCHEMBL29018091 | 0.84 | CA12 (0.47) | TTRFABP4CCNA2CDK2MAPK14 | |
| SCHEMBL21725437 | 0.83 | TTR (0.60) | TTRFABP4CCNA2CDK2MAPK14 | |
| SCHEMBL27459951 | 0.81 | TTR (0.59) | TTRFABP4CCNA2CDK2MAPK14 | |
| SCHEMBL6254 | 0.80 | CA12 (0.54) | TTRCA12CA9CA3CA4 | |
| SCHEMBL29349851 | 0.80 | CA12 (0.54) | TTRCA12CA9CA3CA4 | |
| SCHEMBL3384286 | 0.79 | CA12 (0.53) | TTRCA12CA9CA3CA4 | |
| SCHEMBL3384278 | 0.79 | CA12 (0.53) | TTRCA12CA9CA3CA4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11952328-B2 | Selective ship inhibitors for treating disease | THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK (US) | 2024-04-09 | — | — | US | claimed |
| US-20200277256-A1 | SELECTIVE SHIP INHIBITORS FOR TREATING DISEASE | THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK | 2020-09-03 | — | — | US | claimed |
| WO-2020081852-A1 | SELECTIVE SHIP INHIBITORS FOR TREATING DISEASE | THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK (US) | 2020-04-23 | — | — | WO | claimed |
| CN-111051469-B | Acid stabilization of quantum dot-resin concentrates and premixes | 昭荣化学工业株式会社 | 2024-06-04 | — | — | CN | disclosed |
| US-11952328-B2 | Selective ship inhibitors for treating disease | THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK (US) | 2024-04-09 | — | — | US | disclosed |
| WO-2022018462-A1 | CATECHOL BASED DERIVATIVES FOR USE IN THE PREVENTION OF DNA DAMAGE | UNIVERSITY OF NEWCASTLE UPON TYNE (GB) | 2022-01-27 | — | — | WO | disclosed |
| US-10961448-B2 | Acid stabilization of quantum dot-resin concentrates and premixes | NANOSYS, INC. (US) | 2021-03-30 | — | — | US | disclosed |
| WO-2020236620-A1 | METHODS FOR PREDICTING RESPONSIVENESS OF CANCER TO FERROPTOSIS-INDUCING THERAPIES | MEMORIAL SLOAN KETTERING CANCER CENTER (US) | 2020-11-26 | — | — | WO | disclosed |
| US-20200277256-A1 | SELECTIVE SHIP INHIBITORS FOR TREATING DISEASE | THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK | 2020-09-03 | — | — | US | disclosed |
| US-20200277256-A1 | SELECTIVE SHIP INHIBITORS FOR TREATING DISEASE | THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK | 2020-09-03 | — | — | US | disclosed |
| WO-2020081852-A1 | SELECTIVE SHIP INHIBITORS FOR TREATING DISEASE | THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK (US) | 2020-04-23 | — | — | WO | disclosed |
| CN-111051469-A | Acid stabilization of quantum dot-resin concentrates and premixes | 纳米系统公司 | 2020-04-21 | — | — | CN | disclosed |
| WO-2018226654-A1 | ACID STABILIZATION OF QUANTUM DOT-RESIN CONCENTRATES AND PREMIXES | SMITH AUSTIN (US) | 2018-12-13 | — | — | WO | disclosed |
| US-20180345638-A1 | ACID STABILIZATION OF QUANTUM DOT-RESIN CONCENTRATES AND PREMIXES | NANOSYS, INC. (US) | 2018-12-06 | — | — | US | disclosed |
| US-20170283733-A1 | DISPERSANT VISCOSITY MODIFIERS WITH SULFONATE FUNCTIONALITY | THE LUBRIZOL CORPORATION | 2017-10-05 | — | — | US | disclosed |
| US-20170283733-A1 | DISPERSANT VISCOSITY MODIFIERS WITH SULFONATE FUNCTIONALITY | THE LUBRIZOL CORPORATION | 2017-10-05 | — | — | US | disclosed |
| WO-2016044262-A1 | DISPERSANT VISCOSITY MODIFIERS WITH SULFONATE FUNCTIONALITY | THE LUBRIZOL CORPORATION (US) | 2016-03-24 | — | — | WO | disclosed |
| WO-1999027921-A2 | COMPOSITIONS AND METHODS FOR MODULATING THE ACTIVITY OF FIBROBLAST GROWTH FACTOR | EISAI CO., LTD. (JP) | 1999-06-10 | — | — | WO | disclosed |
| US-4841030-A | Azo reactive dyestuffs | BAYER AKTIENGESELLSCHAFT (DE) | 1989-06-20 | — | — | US | disclosed |
| US-4089895-A | COUPLER FOR AZO DYES | BAYER AKTIENGESELLSCHAFT (DT) | 1978-05-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200277256-A1 | SELECTIVE SHIP INHIBITORS FOR TREATING DISEASE | PPP5C, MTMR1, PPM1G | TTR 1675/4885FABP4 1510/4885CCNA2 3763/4885 |
| US-11952328-B2 | Selective ship inhibitors for treating disease | PPM1A, MTMR1, PPM1B | TTR 2064/4885FABP4 854/4885CCNA2 4044/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.